Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | BPC Instruments AB: BPC Instruments receives orders from KU Leuven valued at 0.7 MSEK | 152 | PR Newswire | LUND, Sweden, June 4, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces orders from KU Leuven university in Belgium. The orders include the delivery of several instruments... ► Artikel lesen | |
28.05. | Bulletin from the Annual General Meeting of BPC Instruments AB | 1 | Cision News | ||
23.05. | BPC INSTRUMENTS AB: Flagging in BPC Instruments | 1 | Cision News | ||
07.05. | BPC Instruments AB: BPC Instruments Annual Report for 2024 | 599 | PR Newswire | LUND, Sweden, May 7, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the Annual Report for the year 2024. The Annual Report is available as an attached file to this release and... ► Artikel lesen | |
07.05. | BPC Instruments AB: BPC Instruments reports results for Q1 2025 | 415 | PR Newswire | LUND, Sweden, May 7, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the interim report for the period January 1 - March 31, 2025. The interim report is available as an attachment... ► Artikel lesen | |
24.04. | Notice of Annual General Meeting in BPC Instruments AB (publ) | 1 | Cision News | ||
BPC INSTRUMENTS Aktie jetzt für 0€ handeln | |||||
10.04. | BPC INSTRUMENTS AB: BPC Instruments appoints new CFO | 1 | Cision News | ||
26.02. | BPC Instruments AB: BPC Instruments reports result for year 2024 | 454 | PR Newswire | LUND, Sweden, Feb. 26, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the year-end report for the year 2024. The year-end report is available as an attached file to this release... ► Artikel lesen | |
26.02. | BPC Instruments AB: BPC Instruments reports result for year 2024 | 255 | PR Newswire | LUND, Sweden, Feb. 26, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the year-end report for the year 2024. The year-end report is available as... ► Artikel lesen | |
20.02. | BPC Instruments AB: BPC Instruments receives order from DairyExperts for animal nutrition research | 382 | PR Newswire | LUND, Sweden, Feb. 20, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces an order of approx. SEK 0.5 million from DairyExperts, a US-based organisation specialising in livestock... ► Artikel lesen | |
12.02. | Bulletin from the Extraordinary General Meeting of BPC Instruments AB (publ) | 1 | Cision News | ||
24.01. | BPC Instruments AB: BPC announces Directed Share Issue to Eiffel Investment Group | 500 | PR Newswire | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
24.01. | Notice of Extraordinary General Meeting in BPC Instruments AB (publ) | 2 | Cision News | ||
08.01. | BPC INSTRUMENTS AB: BPC Instruments expands to new facility in Lund | 1 | Cision News | ||
08.01. | WIHLBORGS FASTIGHETER AB: New build by Wihlborgs for BPC Instruments in Lund | 5 | Cision News | ||
20.12.24 | BPC Instruments AB: Berenberg acquires shares in BPC | 616 | PR Newswire | LUND, Sweden, Dec. 20, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces that the Berenberg European Micro Cap Fund has acquired 4.8 percent of outstanding shares in BPC via... ► Artikel lesen | |
12.12.24 | BPC Instruments AB: BPC Instruments receives orders of 1,1 MSEK for newly launched BPC Air | 704 | PR Newswire | LUND, Sweden, Dec. 12, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") is pleased to announce orders from KTH Sweden and University of Texas USA, totaling 1,1 MSEK. These orders include... ► Artikel lesen | |
14.11.24 | BPC Instruments AB: BPC Instruments reports results for the period January - September 2024 | 1.036 | PR Newswire | LUND, Sweden, Nov. 14, 2024 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the interim report for the period January 1-September 30, 2024. The interim report is available as an attached... ► Artikel lesen | |
23.09.24 | BPC Instruments AB: BPC Instruments launches the BPC Titan - a new solution for gas flow and volume monitoring in pilot and small scales fermentation processes | 827 | PR Newswire | LUND, Sweden, Sept. 23, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces the global launch of its latest innovation, the BPC Titan, specifically designed for biological fermentation... ► Artikel lesen | |
28.08.24 | BPC Instruments AB: BPC Instruments reports results for H1 and Q2 2024 | 661 | PR Newswire | LUND, Sweden, Aug. 28, 2024 /PRNewswire/ -- BPC Instruments ("BPC" or "the Company") hereby publishes the half-year report for the period January 1-June 30, 2024. The half-year report is... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
QIAGEN | 40,060 | -0,55 % | DEUTSCHE BANK RESEARCH stuft QIAGEN NV auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Qiagen von 47 auf 50 US-Dollar angehoben und die Einstufung auf "Buy" belassen. Analyst Jan Koch zog in seinem am Dienstag... ► Artikel lesen | |
PHATHOM PHARMACEUTICALS | 8,920 | +90,19 % | Phathom surges 125% after FDA grants petition on Voquezna exclusivity | ||
BIONTECH | 95,35 | +0,05 % | Milliardenschwere Kooperation von Biontech und US-Konzern | Mainz - Biontech wird die weitere Entwicklung eines seiner vielversprechendsten Wirkstoffkandidaten zur Behandlung von Krebs gemeinsam mit dem US-Konzern Bristol-Myers Squibb vorantreiben. Eine Vereinbarung... ► Artikel lesen | |
RECURSION PHARMACEUTICALS | 5,485 | +20,02 % | Recursion rises on launch of Boltz-2 in partnership with MIT | ||
VERA THERAPEUTICS | 22,760 | -25,69 % | Vera Therapeutics Announces Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial in Adults with IgA Nephropathy | Atacicept ORIGIN Phase 3 trial met the primary endpoint of reduction in proteinuria (UPCR) at week 36; participants receiving atacicept achieved a 46% reduction from baseline and 42% reduction compared... ► Artikel lesen | |
EVOTEC | 7,060 | +0,94 % | DAX-Check LIVE: Douglas, Evotec, Fresenius, Merck, Renk, SAP im Fokus | Der DAX konnte seine anfänglichen Gewinne am Donnerstag nicht halten und rutschte im Tagesverlauf ins Minus. Er schloss 0,44 Prozent tiefer und entfernte sich damit weiter von seinem Rekordhoch bei... ► Artikel lesen | |
SPRINGWORKS THERAPEUTICS | 46,790 | -0,02 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics erhält positive CHMP-Stellungnahme für Mirdametinib zur Behandlung erwachsener und pädiatrischer Patienten mit NF1-PN | - im Falle einer Marktzulassung wäre Mirdametinib die erste und einzige Behandlung in der Europäischen Union für Erwachsene und Kinder mit NF1-PN -
- die Entscheidung der Europäischen Kommission... ► Artikel lesen | |
MODERNA | 23,805 | +1,08 % | Die US-Regierung streicht Moderna ohne erkennbaren Druck etliche Millionen an Fördergeldern für Pandemie-Bekämpfung | Es liegt wohl in der Natur des Menschen, sich über alles nur Erdenkliche zu streiten. Allerdings dürfte es auch Themen geben, bei denen weitgehend Einigkeit herrscht. Dazu gehört die Bekämpfung von... ► Artikel lesen | |
SUMMIT THERAPEUTICS | 20,615 | +4,49 % | Summit Therapeutics crasht - BioNTech in Sippenhaft | Wie gewonnen, so zerronnen: Die Aktie von Summit Therapeutics brach am vergangenen Freitag an der Nasdaq um rund 30 Prozent ein. Weitere Studiendaten zum großen Hoffnungsträger Ivonescimab, den die... ► Artikel lesen | |
BEAM THERAPEUTICS | 18,570 | +9,24 % | Beam Therapeutics Announces Orphan Drug Designation For BEAM-101 | WASHINGTON (dpa-AFX) - Beam Therapeutics (BEAM) announced that the FDA has granted orphan drug designation to BEAM-101, an investigational genetically modified cell therapy for the treatment... ► Artikel lesen | |
MOONLAKE IMMUNOTHERAPEUTICS | 46,880 | -3,99 % | ROUNDUP/Aktien New York: Knappes Plus - Gelassenheit trotz Zoll-Unruhen | NEW YORK (dpa-AFX) - Die US-Börsen haben am Dienstag knappe Kursgewinne erzielt. Die jüngst wieder aufflackernden, internationalen Handelsstreitigkeiten wegen der amerikanischen Zollpolitik scheinen... ► Artikel lesen | |
CG ONCOLOGY | 26,880 | +0,94 % | CG Oncology Inc.: CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates | - Updated BOND-003 clinical results presented at AUA showing best-in-disease durability and tolerability data for Cohort C with 24-month complete response rate of 42.3% by K-M -- Promising early signal... ► Artikel lesen | |
ARCUTIS BIOTHERAPEUTICS | 14,370 | +6,37 % | Arcutis Unveils Long-Term Efficacy, Safety For Zoryve Cream In Pediatric Patients With Atopic Dermatitis | ||
KINIKSA PHARMACEUTICALS | 30,250 | +2,47 % | Kiniksa Pharmaceuticals, Ltd.: Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis | - KPL-387 Phase 2/3 trial on track to initiate in mid-2025; Phase 2 data expected in 2H 2026 -- KPL-387 Phase 1 single ascending dose data support profile for monthly dosing -- Presentation and webcast... ► Artikel lesen | |
DYNE THERAPEUTICS | 14,720 | +5,22 % | Dyne Therapeutics, Inc. - 8-K, Current Report |